FDA Approves First Drug For Progressive Multiple Sclerosis


This week, the Food and Drug Administration approved the first drug to treat primary progressive multiple sclerosis, the most severe form of the disease. Ocrelizumab, commercially known as Ocrevus, will become available to the public in two weeks, and represents hope for a group of MS patients who had no drug options, CNN reported. It has…


FDA Approves First Drug For Progressive Multiple Sclerosis
FDA Approves First Drug For Progressive Multiple Sclerosis

Comments

Loading Facebook Comments ...
Loading Disqus Comments ...